Buprenorphine 8 mg
1 INDICATIONS AND USAGE Buprenorphine sublingual tablets are indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablets contain buprenorphine, a partial opioid agonist, and are indicated for the treatment of opioid dependence and is preferred for induction. ( 1 ) Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
actavis pharma, inc.
OVAL ORANGE logo 153
logo 153 OVAL ORANGE
Related Pills
Buprenorphine 2 mg
actavis pharma, inc.
Buprenorphine 8 mg
actavis pharma, inc.
Buprenorphine 8 mg
Actavis Pharma, Inc.
Buprenorphine 8 mg
actavis pharma, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED / STORAGE AND HANDLING
BUPRENORPHINE sublingual tablets are available as follows: 2 mg – orange, oval tablets debossed with on one side and 156 on the other side. Tablets are supplied in bottles of 30 (NDC 0228-3156-03). 8 mg – orange, oval tablets debossed with on one side and 153 on the other side. Tablets are supplied in bottles of 30 (NDC 0228-3153-03). Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in USP. Store
BUPRENORPHINE sublingual tablets securely and dispose of properly [see Patient Counseling Information ( 17 )] . tablets debossed tablets debossed
More pills like OVAL logo 153